Bio-Techne Cp Cmn (TECH) 112.74 $TECH Techne Up 28.4%

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 5:08 AM

Bio-Techne Cp Cmn (TECH) 112.74 $TECH

Techne Up 28.4% Since SmarTrend Uptrend Call (TECH)
Comtex SmarTrend(R) - Wed Jun 08, 1:04AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 28.45% as of today's recent price of $112.92.
TECH: 112.74 (+1.55)

Uptrend Call Working As Techne Stock Rises 24.8% (TECH)
Comtex SmarTrend(R) - Tue May 31, 1:48PM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 24.79% as of today's recent price of $109.70.
TECH: 112.74 (+1.55)

Watch for Techne to Potentially Pullback After Gaining 2.36% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:18PM CDT
Techne (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $106.43 to a high of $109.93. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $108.18 on volume of 111,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TECH: 112.74 (+1.55)

Techne Shares Up 19.6% Since SmarTrend's Buy Recommendation (TECH)
Comtex SmarTrend(R) - Tue May 24, 1:28AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 19.55% as of today's recent price of $105.10.
TECH: 112.74 (+1.55)

TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 4.80 (+0.22), TECH: 112.74 (+1.55), EXAC: 26.30 (+0.18), NVRO: 74.10 (+4.07)

Bio-Techne (TECH): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:38AM CDT
Are you a technical investor? If so, it may be time to consider Bio-Techne Corp. (TECH) for your portfolio
TECH: 112.74 (+1.55)

Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology
PR Newswire - Wed May 04, 5:00AM CDT
Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration agreement which gives Bio-Techne access to gene editing technology.
TECH: 112.74 (+1.55)

Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Wed May 04, 3:13AM CDT
Techne (NASDAQ:TECH) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $100.55 on volume of 595,000 shares, above average daily volume of 231,000. Techne Corporation, through Research and Diagnostic Systems, Inc., manufactures biological products. The Company also, through R&D Systems Europe, Ltd., distributes biotechnology products.
TECH: 112.74 (+1.55)

Bio-Techne Releases Third Quarter Fiscal 2016 Results
PR Newswire - Tue May 03, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2016.
TECH: 112.74 (+1.55)

Bio-Techne Declares Dividend
PR Newswire - Tue May 03, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2016. The quarterly dividend will be payable May 27, 2016 to all common shareholders of record on May 13, 2016. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
TECH: 112.74 (+1.55)

Bio-Techne To Host Conference Call On May 3, 2016 To Announce Third Quarter Financial Results
PR Newswire - Mon Apr 11, 3:00PM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, May 3, 2016, at 8:00 a.m. CDT to review third quarter fiscal 2016 financial results.
TECH: 112.74 (+1.55)

Zacks Investment Ideas feature highlights: Tech Data, Johnson Outdoor, Central Garden and Delta Apparel
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:30AM CDT
Zacks Investment Ideas feature highlights: Tech Data, Johnson Outdoor, Central Garden and Delta Apparel
DLA: 22.55 (+0.45), CENT: 22.30 (-0.04), TECH: 112.74 (+1.55), JOUT: 26.24 (+0.35)

Bio-Techne Buys Zephyrus, Boosts Protein Platforms Division
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:20AM CDT
Bio-Techne Corp (TECH) recently acquired Zephyrus Biosciences, which will be integrated into the former's Protein Platforms Division.
BPMC: 19.53 (+0.79), TECH: 112.74 (+1.55), AMAG: 24.89 (+0.43), ANIK: 51.10 (+0.83)

Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
PR Newswire - Mon Mar 21, 9:34AM CDT
Bio-Techne Corporation (NASDAQ: TECH) announced today that it has completed the acquisition of Zephyrus Biosciences. Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne.
TECH: 112.74 (+1.55)

Bio-Techne (TECH) Q2 Earnings Match, Sales Beat Estimates
Zacks Equity Research - Zacks Investment Research - Wed Feb 03, 11:40AM CST
Bio-Techne Corp. (TECH) reported adjusted earnings of 82 cents per share in the second quarter of fiscal 2016, in line with the Zacks Consensus Estimate.
TECH: 112.74 (+1.55), ATRA: 22.06 (+0.13), BXLT: 46.02 (-0.18), ANIK: 51.10 (+0.83)

Bio-Techne (TECH) Looks Good: Stock Moves 5.4% Higher
Zacks Equity Research - Zacks Investment Research - Wed Feb 03, 7:00AM CST
Bio-Techne (TECH) was a big mover last session with its shares rising over 5% on the day.
TECH: 112.74 (+1.55), BXLT: 46.02 (-0.18)

Bio-Techne Releases Second Quarter Fiscal 2016 Results
PR Newswire - Tue Feb 02, 6:00AM CST
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2015.
TECH: 112.74 (+1.55)

ProteinSimple Unveils the New Single Analyte Cartridge for Simple Plex(TM)
PR Newswire - Fri Jan 29, 3:30PM CST
ProteinSimple announced today an expansion of the Simple Plex(TM) immunoassay offering by launching a new single analyte cartridge for the analysis of 72 samples at once. This new cartridge enables Simple Plex users to run 72 samples in an hour with triplicate results. It is powered by R&D Systems® reagents, the expert in immunoassays.
TECH: 112.74 (+1.55)

22.4% Return Seen to Date on SmarTrend Techne Call (TECH)
Comtex SmarTrend(R) - Tue Jan 19, 1:55PM CST
SmarTrend identified a Downtrend for Techne (NASDAQ:TECH) on August 12th, 2015 at $106.71. In approximately 5 months, Techne has returned 22.39% as of today's recent price of $82.82.
TECH: 112.74 (+1.55)

Techne Shares Down 21.0% Since SmarTrend's Sell Call (TECH)
Comtex SmarTrend(R) - Tue Jan 12, 12:18PM CST
SmarTrend identified a Downtrend for Techne (NASDAQ:TECH) on August 12th, 2015 at $106.71. In approximately 5 months, Techne has returned 21.04% as of today's recent price of $84.26.
TECH: 112.74 (+1.55)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephen A. Smith Calls for Corporate Support of HBCUs

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

University of Phoenix Unveils Credit for Prior Learning Advantages

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Estrogen Patch Struggles: Menopause Care Needs a Boost

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Salus Scientific Pioneers Safety at TCT 2026

Revolutionizing Occupational Safety in Healthcare Radiation exposure in the medical field: the dull, ominous toll it takes on healthcare professionals, often cloaked in acceptance as a mere occupational hazard. But here's Salus Scientific crashing into the party at TCT 2026 like a seasoned rockstar, demanding we stop accepting the dangers of fluoroscopy-guided procedures...

Millrose Faces Securities Fraud Suit Amidst Decline

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Miraculous Medical Team Effort Saves Newborn's Life

A Medical Feat: Teamwork at Its Pinnacle You want a story that restores your faith in humanity? Well, this one from Memorial Healthcare System and Joe DiMaggio Children's Hospital might just do the trick. The tale of baby Jay'ce, born with a neck mass threatening his breath, is straight out of a medical drama—albeit without the Hollywood scriptwriters' spin. It’s rare...

Biotech's Future Faces Tight Investment Restrictions

Biotech Investment: Between a Rock and a Hard Place The U.S. Department of the Treasury just threw a curveball at the biotechnology sector with its proposal to shore up the Comprehensive Outbound Investment National Security (COINS) Act. This ain't just another set of lines on a folded napkin; the new rules would put a chokehold on American investments flowing into...

Beyond The Bounce Expands with Pro Pickleball Star

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

FP Movement Opens Energizing Boutique in Cranston, RI

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...